Bayer Aktiengesellschaft (ETR:BAYN) Shares Down 2.9% – What’s Next?

Shares of Bayer Aktiengesellschaft (ETR:BAYN) traded down 2.9% during trading on Thursday . The company traded as low as €47.53 and last traded at €47.71. 2,371,699 shares changed hands during mid-day trading, The stock had previously closed at €49.12.

Bayer Aktiengesellschaft Price Performance

The firm has a market cap of $48.17 billion, a P/E ratio of -54.74, a PEG ratio of 36.39 and a beta of 0.83. The company has a debt-to-equity ratio of 134.81, a current ratio of 1.06 and a quick ratio of 0.72. The company’s 50-day moving average is €40.88 and its two-hundred day moving average is €40.89.

About Bayer Aktiengesellschaft

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines for self-medication and self-care; and solutions for nutritional supplements, allergy, cough and cold, dermatology, pain and cardiovascular risk prevention, and digestive health.